Day: April 20, 2020

AMITYVILLE, NY, April 20, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE ‒ Iconic Brands, Inc. (OTCQB: ICNB) (“Iconic” or the “Company”), a lifestyle branding company with the highest expertise of developing, from inception to completion, alcohol beverage products for itself and third parties, today announced that it will be presenting at the Planet MicroCap Showcase 2020 on Wednesday, April 22, 2020, at 3 p.m. EST. Richard DeCicco, Chief Executive Officer of Iconic Brands, will be presenting and answering questions from investors.Event: Planet MicroCap Showcase Virtual Investor Conference 2020Date: Wednesday, April 22, 2020Time: 3 p.m. Eastern TimeWebcast: https://www.webcaster4.com/Webcast/Page/2059/34331“Now is a great time to connect with the investment community to update them on the exciting Iconic story,” stated Richard DeCicco,...

LEI-kode: 213800BGF1TQB5M6PH65Selskabsmeddelelse nr. 5/2020Resultatet for 1. kvartal 2020 samt forventningerne til året som helhed.Møns Bank justerer forventningerne til resultatet før skat for 2020.Møns Banks basisdrift i 1. kvartal 2020 blev 10,8 mio. kr., hvilket er 3,3 mio. kr. bedre end samme periode sidste år og væsentligt over bankens egne budgetforventninger for perioden. Forventningerne til basisdriften for året som helhed er uændrede 25-35 mio. kr. I disse forventninger er indeholdt en usikkerhed om fastholdelsen af det høje aktivitetsniveau fra 1. kvartal 2020 i den resterende del af året, som følge af situationen med Covid 19.Resultat før skat for 1. kvartal 2020 udgør 6,2 mio. kr.Resultatet før skat er præget af, at banken i 1. kvartal 2020 har valgt at nedskrive 5,2 mio. kr. som følge af Coronavirus-krisen, herunder med...

TEL-AVIV, Israel, April 20, 2020 (GLOBE NEWSWIRE) —  Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced a transaction resulting in expected gross cash proceeds to Kitov of approximately $6.5 million, prior to deducting placement agent fees and estimated offering expenses, through the exercise of existing warrants by multiple holders to purchase 20.0 million  of the Company’s American Depositary Shares (“ADSs”) at an exercise price of $0.325 per share.  The ADSs issued upon exercise of the warrants are registered pursuant to Kitov’s registration statement on Form F-1 (File No. 333-235729), as amended, relating to such ADSs, which registration statement was declared effective by the Securities and Exchange...

– Work completed over decades of renowned biochemist’s career serves as basis for Company’s structure-based technology which has demonstrated broad utility in development of proprietary antivirals –BOTHELL, WA, April 20, 2020 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, announced today the appointment of Dr. Roger Kornberg to its Board of Directors. Dr. Kornberg has served as the Company’s Chief Scientist and Chairman of our Scientific Advisory Board.Dr. Kornberg is a member of the U.S. National Academy of Sciences and the Winzer Professor of Medicine in the Department of Structural Biology at Stanford University. He has been a member of the faculty of Stanford University since...

SECAUCUS, N.J., April 20, 2020 (GLOBE NEWSWIRE) — Freshpet, Inc. (NASDAQ: FRPT) (“Freshpet” or the “Company”) today announced it will report results for the first quarter ended March 31, 2020 on Monday, May 4, 2020 after market close.The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details. The conference call is scheduled to begin at 4:30 p.m. ET on Monday, May 4, 2020. To participate on the live call, listeners in North America may dial (877) 407-0792 and international listeners may dial (201) 689-8263.In addition, the call will be broadcast live over the Internet, hosted at the “Investor” section of the Company’s website at www.freshpet.com and will be archived online. A telephonic playback will be available from 7:30 p.m. ET, May...

Öll hlutabréf í B-deild stofnsjóðs Sláturfélags Suðurlands svf. hafa verið tekin til rafrænnar skráningar í kerfi Nasdaq verðbréfamiðstöðvar hf. í dag 20. apríl 2020.  Frá þeim tíma eru hin áþreifanlegu hlutabréf í félaginu ógild.Að lokinni rafrænni skráningu geta hluthafar nálgast hluti sína sem og arð með því að fela reikningsstofnun sem gert hefur aðildarsamning við Nasdaq verðbréfamiðstöð hf. umsjón með eignarhlut sínum í félaginu og stofna vörslureikning.  Arður verður framvegis einungis greiddur út í gegnum kerfi Nasdaq verðbréfamiðstöðvar hf.Stjórn Sláturfélags Suðurlands svf.

SAN DIEGO, April 20, 2020 (GLOBE NEWSWIRE) — Histogen Inc., a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, announced today that it has submitted an Investigational Device Exemption (IDE) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical trial of HST 002 for the treatment of facial folds and wrinkles.HST 002 is a naturally produced collagen and extracellular matrix dermal filler targeting the treatment of facial folds and wrinkles. The planned Phase 1 clinical trial is designed to assess the safety and tolerability of HST 002, as well as look for early indications of efficacy versus a placebo control.“The submission of this Investigational Device Exemption for HST 002 is an important milestone for Histogen as we...

SAN DIEGO, April 20, 2020 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that Kratos Unmanned Systems Division has received a $2.7 million sole-source option award for Command and Control System Mission Kits to support U.S. drone operations. Kratos is the design and qualification authority and this award is part of the follow-on production program. Production is now in its second year of a 5 year IDIQ contract.Steve Fendley, President of Kratos Unmanned Systems Division, said, “Our primary focus and commitment remains developing and supporting cost-effective unmanned systems for our nation’s warfighter. During these unusual times, we are dual-hatted, focused on keeping our company personnel and communities safe, while continuing to...

SECURITIES REPURCHASING PROGRAMME(Decided by the annual shareholders’ meeting of 17 May 2019)Disclosure of trading in own sharesPeriod from 10 to 16 April 2020Issuer : COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELINLEI : 549300SOSI58J6VIW052Types of securities: ordinary shares (ISIN : FR 0000121261)Full details of the programme disclosed on 7 January 2020Purchases effected during the period:(*) Shares purchased through a derivative instrument are included. Are excluded transactions carried out in connection with the execution of a contract to increase share market liquidity.AttachmentModèle EN déclaration hebdo 20.04.2020

PROGRAMME DE RACHAT DE TITRES(Programme adopté par l’assemblée générale mixte des actionnaires le 17 mai 2019)Déclaration des transactions sur actions propresPériode du 10 au 16 avril 2020Emetteur : COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELINLEI : 549300SOSI58J6VIW052Catégories de titres : actions ordinaires (ISIN : FR 0000121261)Descriptif du programme publié le 7 janvier 2020Achats réalisés au cours de la période :(*) Y compris les titres acquis par l’intermédiaire d’un produit dérivé, mais compte non tenu des opérations réalisées dans le cadre de l’exécution d’un contrat de liquidité.Pièce jointeModèle FR déclaration hebdo 20.04.2020